Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules

Murui Zhang,Xiaotong Hu,Lunming Liu,Yihong Wang,Junchang Jiang,Hui Li,Weiqiang Fei,Tingting Zhong,Zhinong Jiang
DOI: https://doi.org/10.1097/md.0000000000035960
IF: 1.6
2024-02-03
Medicine
Abstract:Thyroid neoplasms are common in the endocrine system, representing the most commonly diagnosed head and neck tumors. In the past few decades, the total incidence rate of thyroid neoplasm has increased about 2-fold and comprised 2% of the cancers. [ 1 ] Thyroid nodules are clinically prevalent and can be detected in approximately 20% to 76% of normal people by ultrasound techniques. [ 2 ] As the development of detecting and surgical techniques, an increasing number of thyroid nodules has been found as malignancy. In this context, early screening and differentiation of benign and malignant thyroid nodules are decisive for clinical decision-making. Currently, ultrasound-guided fine-needle aspiration cytology (FNAC) is widely applied in the preoperative diagnosis of benign and malignant thyroid nodules. It is interpreted based on The Bethesda System for Reporting Thyroid Cytopathology (BSRTC). However, a definitive diagnosis still cannot be achieved via the FNA for 15–30% of nodules. [ 3 , 4 ]
medicine, general & internal
What problem does this paper attempt to address?